Cxcr4 antagonistic peptide and cytarabine for the treatment of myeloid leukemia

摘要

There is provided a method of treating a myeloid leukemia. The method includes the step of administering to a subject in need thereof a therapeutically effective amount of a CXCR4-antagonistic peptide and a therapeutically effective amount of a chemotherapeutic agent.